Skip to main navigation Skip to search Skip to main content

Shutdown dose rate studies for the DTE2 campaign at JET

    Research output: Contribution to journalArticlepeer-review

    11 Citations (Scopus)

    Abstract

    The EUROfusion Work Package JET3 programme, established to enable the technological exploitation of the future Deuterium-Tritium (DT) operations at JET over the next years, includes, within the NEXP subproject, a novel Shutdown Dose Rate (SDR) benchmark experiment. The measurement of the SDR due to neutron activation in a fusion machine operating with Deuterium and Tritium is of primary importance for planning its operation in respect of dose limits for the external radiation exposure. The next high-performance DT campaign at JET (DTE2) which will follow a Tritium-Tritium (TT) operation phase, is a unique opportunity to validate the numerical tools for ITER shutdown dose rate analysis, through the comparison between numerical predictions and measured quantities in terms of C/E (Calculation/Experiment) ratios. Within this framework, this work is a pre-analysis of the impact of the future campaigns on the shutdown dose rate. Three-dimensional simulations are performed with the R2Smesh (Rigorous 2-step) approach at the end of DTE2 to predict dose rate levels at different cooling times. The results are presented and discussed in the paper with the major objective to contribute to the optimization of the planned SDR benchmark experiments.

    Original languageEnglish
    Article number112009
    JournalFusion Engineering and Design
    Volume161
    DOIs
    Publication statusPublished - Dec 2020

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 7 - Affordable and Clean Energy
      SDG 7 Affordable and Clean Energy

    Keywords

    • Deuterium tritium campaign
    • DTE2
    • JET
    • Shutdown dose rate
    • TT

    OECD Field of Science

    • 1.3 Physical Sciences

    Fingerprint

    Dive into the research topics of 'Shutdown dose rate studies for the DTE2 campaign at JET'. Together they form a unique fingerprint.

    Cite this